The Fraser Eye Care Center Doctors have either authored or reviewed and approved this content.
We’ve expanded! Visit Fraser Eye’s new location — West Bloomfield
Menu
Page Updated:
Fraser Eye proudly serves patients in Detroit throughout Michigan, providing advanced ophthalmic care supported by innovation and research. Our physicians partner with leading global companies to evaluate new treatments and technologies that may improve sight and enhance quality of life for patients.
As part of our commitment to medical advancement, we offer opportunities to participate in clinical research studies across multiple subspecialties, including cataract surgery, glaucoma, and corneal disease. Learn more about our current and completed studies below.
Cataract and Glaucoma Study – SpyGlass Pharma
Open-Angle Glaucoma and Cataracts – Alcon
Cataract and Glaucoma Study – SpyGlass Pharma
Open-Angle Glaucoma and Cataracts – Alcon
Open-Angle Glaucoma & Ocular Hypertension – AbbVie
Persistent Corneal Epithelial Defects – Glaukos
Thyroid Eye Disease - Viridian (2025)
Active Thyroid Eye Disease – Viridian (2024)
Open-Angle Glaucoma or Ocular Hypertension – Glaukos (2024)
Thyroid Eye Disease – Viridian (2024)
Chronic Thyroid Eye Disease – Viridian (2024)
Presbyopia – Ocuphire/Opus (2024)
Cataract with Open-Angle Glaucoma or Ocular Hypertension – SpyGlass Pharma (2024)
Open-Angle Glaucoma – Perfuse Therapeutics (2024)
Open-Angle Glaucoma or Ocular Hypertension – AbbVie (2023)
Diabetic Retinopathy – Perfuse Therapeutics (2024)
Dry Eye Disease – Sylentis (2022)
Open-Angle Glaucoma or Ocular Hypertension – Thea (2022)
Post Cataract Surgery – Kowa Research Institute, INC (2022)
Open Angle Glaucoma and Cataracts – Ivantis (2022)
Post Cataract Surgery – Formosa (2021)
Glaucoma– Allergan (2020)
Open Angle Glaucoma or Ocular Hypertension – AbbVie (2020)
Contact Lens– Alcon (2019)
Aphakia – Alcon (2019)
Open Angle Glaucoma – AbbVie (2019)
Open Angle Glaucoma – AbbVie (2019)
Open Angle Glaucoma and Cataract – Alcon (2017)
Visual Field Change – Pfizer (2017)
Open Angle Glaucoma or Ocular Hypertension – Ocular Therapeutics (2017)
Open Angle Glaucoma – AbbVie (2016)
Participating in a clinical trial allows patients to access new and emerging treatments while helping advance the future of eye care. Potential benefits include:
All studies are conducted under strict safety protocols and ethical oversight to protect participants.
To learn more about ongoing or upcoming clinical trials at Fraser Eye—or to find out if you may qualify—please contact our Study Coordinator Hailey Moody at 586-296-7250, Ext 114.
You can also complete the form below to be added to our research interest list, and a member of our team will reach out with more information.
The Fraser Eye Care Center Doctors have either authored or reviewed and approved this content.
